Posted inBiotechnology
Delirium Rates in German Nursing Homes Revealed in New Study
A groundbreaking new study has brought to light the pervasive issue of delirium among elderly residents in German nursing homes.…
Posted inBiotechnology
Unraveling How General Anesthesia Works at the Molecular Level
Scientists Uncover How Anesthetic Sevoflurane Locks Sodium Channels to Silence Neurons Despite inhaled anesthetics being a cornerstone of surgical practice…
Posted inBiotechnology
First Clinical Trial of Stem Cell Therapy for Huntington’s Disease Announced
A groundbreaking clinical trial has commenced, evaluating a pluripotent stem cell-derived neural stem cell therapy for Huntington’s disease (HD), marking…
Posted inBiotechnology
Plant Viruses Boost AI, Machine Learning, and Nanotech in Biotechnology
Plant Viruses: Revolutionizing Biotechnology through AI, Machine Learning, and Nanotechnology Emerging research is unveiling the profound potential of plant viruses…
Posted inBiotechnology
Stem Cell Therapy Shows One-Year Survival in Retinitis Pigmentosa Patients
At ISSCR 2026, groundbreaking clinical data revealed the long-term survival of human neural progenitor cells transplanted into patients with retinitis…
Posted inBiotechnology
Türkiye Launches Light Office, New Hub for Optical Research
A New Era for Optical Science: The Launch of Light Office in Türkiye In a significant stride forward for the…
Posted inBiotechnology
Long-Term Stem Cell Data Boosts Chronic Stroke Recovery Research
Long-term Clinical Data Unveil Promise of iPSC-Derived Neural Progenitor Cells in Chronic Stroke Recovery In a breakthrough presentation at the…
Posted inBiotechnology
Hantavirus Risks and Pandemic Potential from Nature Cruises Explored
Concerns Rise Over Emerging Hantavirus Cases and Viral Threats Like Ebola In May 2026, the medical community was alerted by…
Posted inBiotechnology
Study Explores Traditional Chinese Medicine for Treating Post-COVID Syndrome
A recent cohort study has shed new light on the use of traditional Chinese medicine (TCM) as a complementary therapy…
Posted inBiotechnology
Bausch + Lomb gives up on glaucoma eye drop hopeful after phase 2 fail
Bausch + Lomb has abandoned its next great hope in glaucoma after the eye drops flunked a phase 2 study.